SkinBioTherapeutics (SBTX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

16.75p
   
  • Change Today:
      0.13p
  • 52 Week High: 26.10
  • 52 Week Low: 8.75
  • Currency: UK Pounds
  • Shares Issued: 258.78m
  • Volume: 2,870,494
  • Market Cap: £43.35m
  • Beta: 0.01

SBTX Overview

SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CSO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester.

Key Personnel

CEO: Stuart Ashman
CFO: Manprit Singh Randhawa
Executive Director: Simon Hewitson
Group Finance Director: Emily Bertram
Independent Non-Executive Director: Catherine Denise Prescott
Non-Executive Chairman: Martin Braddock Hunt
Non-Executive Dir: Danielle Bekker

Contact Details

Address: The Core, Bath Lane, Newcastle Helix, Newcastle upon Tyne, United Kingdom, NE4 5TF
Phone: +44 191 495 7325
Website: http://www.skinbiotherapeutics.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BF33H870

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

SBTX Market Data

Currency UK Pounds
Share Price 16.75p
Change Today 0.13p
% Change 0.75 %
52 Week High 26.10
52 Week Low 8.75
Volume 2,870,494
Shares Issued 258.78m
Market Cap £43.35m
Beta 0.01

SBTX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.88% below the market average70.88% below the market average70.88% below the market average70.88% below the market average70.88% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Price Trend
57.48% above the market average57.48% above the market average57.48% above the market average57.48% above the market average57.48% above the market average
82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average82.61% above the sector average
Income Not Available
Growth
48.78% above the market average48.78% above the market average48.78% above the market average48.78% above the market average48.78% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average

SBTX Dividends

No dividends found

Trades for 07-Jul-2025

Time Volume / Share Price
17:07 75,000 @ 16.75p
16:17 1,603 @ 16.97p
15:18 42,411 @ 16.78p
13:07 500,000 @ 17.00p
12:49 500,000 @ 16.95p

SBTX Key Personnel

CEO Stuart Ashman
CFO Manprit Singh Randhawa

Top of Page